SLC6A3 and metabolic dysfunction-associated steatotic liver disease: Comparison of the distribution of patient and control cells and DAT showed a mild depletion of cells with medium expression of MHC II genes in MASLD and a pronounced increase in abundance of a small subset of cells with low MHC II expression in patients with MASLD (Figure 5C/D).